Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial

BACKGROUND: Neoadjuvant endocrine therapy (NET) has been demonstrated to improve breast-conserving rate and is a widely accepted treatment option for postmenopausal patients with hormone receptor-positive breast cancer. There are few reports on the association of NET response and long-term outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Takayuki, Saji, Shigehira, Masuda, Norikazu, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Iwata, Hiroji, Yamanaka, Takeharu, Sasano, Hironobu, Toi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844383/
https://www.ncbi.nlm.nih.gov/pubmed/29531841
http://dx.doi.org/10.1136/esmoopen-2017-000314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844383/
https://www.ncbi.nlm.nih.gov/pubmed/29531841
http://dx.doi.org/10.1136/esmoopen-2017-000314

Ejemplares similares